people's pharmacy semaglutide BOOST BUNDLE – Paul's Ozempic Maker Plans to Study

L CARNITINA EMAGRECE

Implications for insurers Insurers should consider the impact of AOMs across their business: Assess how AOMs may impact protection, morbidity, and longevity experience Review trend assumptions to identify whether changes are needed Establish processes to keep on top of this fast-moving space Consider new lapse risks Assess how AOMs might affect underwriting and claims Insured impacts and reviewing trend assumptions Insurers should consider adjustments to their specific mortality and morbidity improvement assumptions to reflect AOMs

It is not FDA-approved in the same way that Ozempic or Wegovy are

You may not be eligible for Ozempic if you: Are pregnant or breastfeeding Have a history of diabetic retinopathy Have or have had problems with your pancreas or kidneys Have a personal or family history of medullary thyroid carcinoma (MTC)or multiple endocrine neoplasia syndrome type 2 (MEN 2) Have a history of severe allergic reactions to semaglutide or other GLP-1 medications Potential medication interactions Ozempic can interact with some medications